UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024386
Receipt number R000028073
Scientific Title To compare effectiveness of taking amino acids in the morning with that in the evening (chrono-nutrition and amino acids.
Date of disclosure of the study information 2016/10/15
Last modified on 2018/04/15 09:55:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

To compare effectiveness of taking amino acids in the morning with that in the evening (chrono-nutrition and amino acids.

Acronym

To compare effectiveness of taking amino acids in the morning with that in the evening (chrono-nutrition and amino acids.

Scientific Title

To compare effectiveness of taking amino acids in the morning with that in the evening (chrono-nutrition and amino acids.

Scientific Title:Acronym

To compare effectiveness of taking amino acids in the morning with that in the evening (chrono-nutrition and amino acids.

Region

Japan


Condition

Condition

Healthy individual

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare effectiveness of taking amino acids in the morning with that in the evening

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Muscle mass of whole body on Days 0, 14, and 28 after initiation of administration and on Day 14 after completion.

Key secondary outcomes

Body weight, amount of body fat, amount of skin moisture, and amount of moisture loss via the skin on Days 0, 14, and 28 after initiation of administration and on Day 14 after completion. Amount of salivary hormone, skin viscous elasticity, and QOL questionnaire.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Taking an amino-acid supplement at the time of awakening and a placebo before bed time is continued for 4 weeks.

Interventions/Control_2

Taking a placebo at the time of awakening and an amino-acid supplement before bed time is continued for 4 weeks.

Interventions/Control_3

Taking a placebo at the time of awakening and before bed time is continued for 4 weeks.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

(1) The age at the time of obtaining a consent is 20 years or older.
(2) Female
(3) Those from whom a written consent can be obtained on a voluntary basis.

Key exclusion criteria

The person who is unsuitable for the entry judged by an officer.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Motoko Takaoka

Organization

Kobe College

Division name

School of Human Sciences, Department of Biosphere Sciences

Zip code


Address

4-1 Okadayama, Nhishinomiya-shi, Hyogo pref. 662-8506 Japan

TEL

0798-51-8668

Email

takaoka@mail.kobe-c.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Taizo Seki

Organization

Noevir Co., Ltd.

Division name

Groupwide Research and Development

Zip code


Address

112-1, Okada-cho, Higashiomi, Shiga

TEL

0748-35-2452

Homepage URL


Email

taizou_seki@n1.noevir.co.jp


Sponsor or person

Institute

Kobe College

Institute

Department

Personal name



Funding Source

Organization

Noevir Co., Ltd.
DAC Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神戸女学院大学(兵庫県)
Kobe College(Hyogo Prefecture)


Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 10 Month 07 Day

Date of IRB


Anticipated trial start date

2016 Year 10 Month 17 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 10 Month 13 Day

Last modified on

2018 Year 04 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028073


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name